Physicochemical Properties
Molecular Formula | C39H37F3N6O5 |
Molecular Weight | 726.74 |
CAS # | 2946593-60-6 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
ln Vitro | (R)-G12Di-7 (1-100 nM) inhibits cell viability of KRAS-G12D mutant cells Ba/F3, SW1990, AsPC-1 and AGS with GI50 values of 73 nM, 409 nM, 467 nM and 109 nM, respectively[1]. (R)-G12Di-7 (10 μM) labels KRAS-G12D in G12D mutant cells Ba/F3, SW1990, AsPC-1 and AGS, thereby inhibiting downstream signaling and maintaining stability within 12 hours[1]. |
ln Vivo | (R)-G12Di-7 (10-50 mg/kg, intraperitoneally, twice a day for 28 days) has antitumor activity in SW1900 xenografted NOD/SCID mice [1]. |
Cell Assay |
Cell Viability Assay[1] Cell Types: Ba/F3, SW1990, AsPC-1, AGS Tested Tested Concentrations: 1-1000 nM Incubation Duration: 72 h Experimental Results: Inhibited cell growth of Ba/F3, SW1990, AsPC-1 and AGS. Western Blot Analysis[1] Cell Types: Ba/F3, SW1990, AsPC-1, AGS Tested Tested Concentrations: 10 μM Incubation Duration: 4 h Experimental Results: Suppressed expression K-RAS-G12D and phosphorylation of ERK and Akt in cells G12D mutated cells Ba/F3, SW1990, AsPC-1 and AGS. |
Animal Protocol |
Animal/Disease Models: SW1900 xenograft NOD/SCID mice[1] Doses: 10-50 mg/kg Route of Administration: i.p., twice a day for 28 days Experimental Results: Inhibited tumor growth and weight loss. |
References |
[1]. Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D. Nat Chem Biol. 2024 Mar 5. |
Solubility Data
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.3760 mL | 6.8800 mL | 13.7601 mL | |
5 mM | 0.2752 mL | 1.3760 mL | 2.7520 mL | |
10 mM | 0.1376 mL | 0.6880 mL | 1.3760 mL |